More from TAILORx investigators By Peggy Peck, Editor-in-Chief, BreakingMED CHICAGO — Clinical risk — high versus low risk — integrated into a genomic risk model is prognostic of distant recurrence of breast cancer in women...
Read More
DNA repair mechanism damage targeted in advanced disease CHICAGO — Patients diagnosed with...
Read More
New survey highlights suspected financial impact CHICAGO – Gynecologic oncologists report that...
Read More
But the FDA wants to know outcomes for patients taking unapproved drugs CHICAGO — The FDA says it...
Read More
Metastatic disease responds to enfortumab vedotin CHICAGO – A new agent that acts as a smart bomb...
Read More
Colon cancer spread excised in minimally invasive procedure CHICAGO – In cases where colon cancer...
Read More
BRCA was the key to success CHICAGO — Pancreatic cancer trials don’t report complete responses,...
Read More
Too little, too late to save Obamacare? CHICAGO — As the nation prepares to once again litigate...
Read MoreZip code can be a risk factor CHICAGO – Multiple myeloma is a serious and often deadly disease, but outcomes may be better for those whose medical care is covered by private insurers. Or, it’s possible all survival, like...
Read More
Survival is about more than testosterone suppression CHICAGO — Men with metastatic hormone...
Read More
Diabetes drug offers no benefit to non-diabetic patients CHICAGO – Metformin, when added to...
Read More
By Peggy Peck, Editor-in-Chief, BreakingMED CHICAGO — Adding the CDK4/6 inhibitor ribociclib to...
Read More
CHICAGO — What if all health systems, all hospitals, and all oncologists spoke the same language —...
Read More
Immunotherapy drug works as well as chemotherapy in advanced patients CHICAGO – In a...
Read More
New research was presented at DDW 2019, the annual Digestive Disease Week, from May 18-21 in San...
Read More
New research was presented at ATS 2019, The annual American Thoracic Society International...
Read More
By Peggy Peck, Editor-in-Chief, BreakingMED In advance of the American Society of Clinical...
Read More
Pediatric cancers are killers that often elude approved therapies, but the advent of precision...
Read More
Some cancers are more common in elderly — often frail— persons, and Peter S. Hall, PhD, a medical...
Read More
By Peggy Peck, Editor-in-Chief, BreakingMED CHICAGO – What is the best way to treat hormone...
Read More
